Login / Signup
Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?
Jordan K Schaefer
Geoffery D Barnes
Published in:
Thrombosis and haemostasis (2024)
Keyphrases
</>
direct oral anticoagulants
venous thromboembolism
atrial fibrillation
stem cells
bone marrow
replacement therapy